This agreement alters the pricing structure for state Medicaid programs, creating potential needs for new compliance, pricing management, and market access analytics solutions. By avoiding future CMS mandates, the company gains regulatory certainty, which may shift strategic resources towards optimizing operations under this new framework.
Filing excerpt
Incyte Corporation (the “Company”) today announced that it has entered into an agreement with the U.S. Centers for Medicare & Medicaid Services (“CMS”) intended to improve access to medicines for American patients while supporting continued U.S. biopharmaceutical innovation.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-8kmaterialContractGet every 8-K signal for Incyte and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Incyte this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/b0363abb-a8d2-40ff-8216-ad39fc56d22d returns this record as JSON. POST /v1/companies/enrich returns every signal for incyte.com.
{
"signal_id": "b0363abb-a8d2-40ff-8216-ad39fc56d22d",
"signal_type": "sec-8k",
"signal_subtype": "materialContract",
"detected_at": "2026-09-01T07:04:06.247+00:00",
"company": {
"name": "Incyte",
"domain": "incyte.com"
},
"data": {
"detail": "This agreement alters the pricing structure for state Medicaid programs, creating potential needs for new compliance, pricing management, and market access analytics solutions. By avoiding future CMS mandates, the company gains regulatory certainty, which may shift strategic resources towards optimizing operations under this new framework.",
"metrics": {
"timeframe": "immediate"
},
"summary": "Incyte enters pricing agreement with CMS for its drugs Jakafi and Jakafi XR",
"excerpts": "Incyte Corporation (the “Company”) today announced that it has entered into an agreement with the U.S. Centers for Medicare & Medicaid Services (“CMS”) intended to improve access to medicines for American patients while supporting continued U.S. biopharmaceutical innovation.",
"relevance": 0.8,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/879169/000087916926000058/incy-20260831.htm",
"filing_date": "2026-08-31",
"filing_year": 2026,
"fiscal_year_end": "08/31",
"sales_relevance": "Vendor relationship signal",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/b0363abb-a8d2-40ff-8216-ad39fc56d22d \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"incyte.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.